אביליפיי 10 מ"ג

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

ARIPIPRAZOLE 10 MG

Dostupno od:

BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED

ATC koda:

N05AX12

Farmaceutski oblik:

TABLETS

Administracija rute:

PER OS

Proizveden od:

BRISTOL-MYERS SQUIBB S.R.L, ITALY

Terapijska grupa:

ARIPIPRAZOLE

Terapijske indikacije:

Abilify is indicated for the treatment of schizophrenia. And for the treatment of moderate to severe manic episodes in Bipolar I disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.

Datum autorizacije:

2010-02-01